Jones Financial Companies
IBIO icon

Jones Financial Companies’s iBio IBIO Stock Holding History

Jones Financial Companies’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$4 – 3460
2024
Q3 		$4 Buy
+2
New +$4 ﹤0.01% 3015

Other funds holding IBIO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jones Financial Companies's IBIO Position: Q4 2024 in Review

Jones Financial Companies sold out of iBio (IBIO) in Q4 2024, closing a stake of 2 shares — an estimated $4 sold.

Jones Financial Companies first reported a position in IBIO in Q3 2024 and held it in 1 quarter. The position peaked at $4 in Q3 2024. 30 funds tracked by Wall St. Rank hold IBIO as of Q4 2024.

  • Jones Financial Companies reported no remaining iBio position as of Q4 2024 after selling out during the quarter.
  • Jones Financial Companies sold 2 iBio shares in Q4 2024, an estimated $4.
  • Jones Financial Companies first reported a position in iBio in Q3 2024 and held it in 1 quarter.
  • Jones Financial Companies's iBio position peaked at $4 in Q3 2024.
  • 30 funds tracked by Wall St. Rank held iBio as of Q4 2024.

Based on Jones Financial Companies's 13F filing for Q4 2024, filed 6 Feb 2025.